Perrigo Company Press Releases

PRGO 
$166.11
*  
1.96
1.19%
Get PRGO Alerts
*Delayed - data as of Dec. 24, 2014  -  Find a broker to begin trading PRGO now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Senior Notes
12/2/2014 1:31:00 PM - PR Newswire
▲5.21 % Price Change since this news event. The Volume Ratio is 1.8.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


GoodSense® Named Official Pain Reliever Of runDisney
12/2/2014 11:03:00 AM - PR Newswire


Perrigo Announces FDA Approval And Launch Of The Generic Version Of Pennsaid® 1.5% w/w
12/2/2014 8:48:00 AM - PR Newswire
▲4.31 % Price Change since this news event. The Volume Ratio is 1.45.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares
11/26/2014 11:51:00 AM - PR Newswire


Perrigo Company plc Announces The Pricing Of Senior Notes Offering By Its Finance Subsidiary, Perrigo Finance plc
11/24/2014 4:42:00 PM - PR Newswire


Perrigo Company plc Announces Underwriters'' Full Exercise Of Option To Purchase Ordinary Shares In Connection With The Equity Offering
11/24/2014 8:48:00 AM - PR Newswire


Perrigo Company plc Announces Proposed Public Offering Of Senior Notes Of Its Finance Subsidiary, Perrigo Finance plc
11/24/2014 8:47:00 AM - PR Newswire


Perrigo Confirms First to File Patent Challenge for Generic Version of Aveed® (Testosterone Undecanoate) Injection
11/24/2014 7:54:00 AM - PR Newswire


Perrigo Announces The Launch Of A Generic Version Of Astellas'' Protopic® Ointment 0.1% And 0.03%
11/24/2014 7:52:00 AM - PR Newswire


Perrigo Company plc Announces the Pricing of its Offering of Ordinary Shares
11/20/2014 8:05:00 PM - PR Newswire


Perrigo Company plc Announces Proposed Public Offering Of Ordinary Shares
11/20/2014 6:49:00 AM - PR Newswire


Perrigo Reinitiates Shipments Of Guaifenesin Extended-Release 600mg Tablets, The Store Brand Equivalent To Mucinex® 600mg Extended-Release Tablets
11/6/2014 6:39:00 AM - PR Newswire
▲4.80 % Price Change since this news event. The Volume Ratio is 6.73.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Perrigo Company PLC Reports Record First Quarter Revenue, Adjusted Net Income And Adjusted Margins
11/6/2014 6:32:00 AM - PR Newswire
▲4.80 % Price Change since this news event. The Volume Ratio is 6.73.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Perrigo Company plc To Acquire Omega Pharma NV For EUR 3.6 Billion Creating A Top Five Global OTC Company
11/6/2014 6:26:00 AM - PR Newswire
▲4.80 % Price Change since this news event. The Volume Ratio is 6.73.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Perrigo Company plc Announces Quarterly Dividend
11/3/2014 3:12:00 PM - PR Newswire
▲3.89 % Price Change since this news event. The Volume Ratio is 1.24.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Perrigo Company plc To Release First Quarter Fiscal Year 2015 Results On November 6, 2014
10/23/2014 8:34:00 AM - PR Newswire
▲10.55 % Price Change since this news event. The Volume Ratio is 1.12.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Perrigo Animal Health Receives SQF Certification
10/14/2014 10:25:00 AM - PR Newswire
▲13.32 % Price Change since this news event. The Volume Ratio is 0.71.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Perrigo Company plc Announces Expiration Of Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023, 5.30% Senior Notes Due 2043
10/2/2014 8:48:00 AM - PR Newswire


Perrigo Company plc Announces Extension of Exchange Offer for Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023, 5.30% Senior Notes Due 2043
10/1/2014 8:53:00 AM - PR Newswire


Perrigo Announces the Out-Licensing of Preclinical Assets to Imago Pharmaceuticals
9/29/2014 7:39:00 AM - PR Newswire


Lumara Health™ to be Acquired in Two Separate Transactions for up to $1.107 Billion
9/29/2014 7:15:00 AM - PR Newswire


Perrigo Enters New Therapeutic Category With The Acquisition Of Women's Health Product Portfolio From Lumara Health
9/29/2014 7:09:00 AM - PR Newswire